Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07046052 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

PENG Block: Continuous Infusion vs. Programmed Intermittent Bolus in Neck of Femur Fracture

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated July 1, 2025 (before its estimated January 7, 2026 completion). Its status may not reflect the trial's current state.

Record History

  1. Study First Submitted
Pericapsular Nerve Group Block (PENG) is an effective regional anaesthesia modality in providing analgesia following neck of femur fracture. Continuous PENG techniques, using indwelling catheters and infusions of local anaesthetic, facilitate the continuation of analgesia for a number of days following hip fracture surgery. It is unclear from the published literature whether an optimal strategy of local anaesthetic delivery has been characterized. Similar doses of local anaesthetic agents can be administered by either continuous infusion or timed intermittent bolus. It is unclear whether one dosing strategy is superior to the other in the context of hip fracture analgesia. The study aims to evaluate the clinical efficacy of both dosing strategies in patients undergoing hip fracture surgery.
Trial Details
NCT Number NCT07046052
Lead Sponsor University College Cork
Conditions
(from sponsor)		 Hip Fracture, Analgesia Post Fracture
Related terms Agnosia, Hip Fractures
Enrollment 150 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov